News Focus
News Focus
icon url

dr_lowenstein

10/19/17 9:58 AM

#40340 RE: guti #40332

I doubt the numbers are quite enough for Merck other than to continue to provide Keytruda for the ongoing clinical trial. These small numbers are hardly revolutionary. But hey, let the fun occur today for a short while LOL